Apparently beating out several competitors that earlier in the year were considered favorites to get the first COVID vaccine to market for distribution in the United States,dark horse favorite Pfizer Inc.seems to be the clear winner,announcing this week that their COVID vaccine is"90%effective,"and that hundreds of millions of doses would be distributed before the end of 2020,pending an FDA emergency use authorization(EUA).
显然击败了几个竞争对手，在今年早些时候被认为是最有希望获得第一个输送到美国市场的COVID疫苗，黑马最受欢迎的辉瑞公司似乎是明显的赢家，本周宣布他们的COVID疫苗是"90%有效"，数亿剂量将在2020年底之前分发，等待 FDA 的紧急使用授权(EUA)。
Of course for those of us who do not follow the propaganda media,and understand that there is not even an accurate test for COVID currently in the market,the question that begs to be answered is:
当然，对于我们这些不关注宣传媒体的人来说，明白目前市场上甚至没有一个准确的检测方法来检测 COVID，亟待回答的问题是:
Effective for what?
对什么有效？
It was announced back in June that Pfizer was one of the finalists in President Trump's Operation Warp Speed program,along with AstraZeneca,Merck,Johnson&Johnson and Moderna.
早在6月份就宣布，辉瑞与阿斯利康、默克、强生和 Moderna 一起进入了特朗普总统的曲速行动决赛。
Should we trust Pfizer's claims?
我们应该相信辉瑞的说法吗？
Do you trust criminal organizations?Because that's what Pfizer is.In fact,they may very well be the largest criminal organization in world.
你相信犯罪组织吗？因为辉瑞就是这样的公司。事实上，他们很可能是世界上最大的犯罪组织。
In 2009 they reached a fraud settlement with the U.S.Department of Justice for$2.3 BILLION,the largest ever fraud settlement in the history of the DOJ at that time.
2009年，他们与美国司法部达成了一项23亿美元的欺诈和解协议，这是当时美国司法部历史上最大的欺诈和解协议。
Since then,they have faced numerous other criminal investigations,the most recent one being reported just yesterday,November 10,2020,with the foreign corruption units at the U.S.Securities and Exchange Commission(SEC)and the Department of Justice(DOJ)looking into their activities in China and Russia.
从那时起，他们面临着许多其他的刑事调查，最近的一次是昨天，2020年11月10日，美国证券交易委员会(SEC)和司法部(DOJ)的外国腐败部门调查了他们在中国和俄罗斯的活动。
Angus Liu,writing for FiercePharma,reports:
刘为 FiercePharma 撰文报道:
The foreign corruption units at the U.S.Securities and Exchange Commission(SEC)and the Department of Justice(DOJ)are looking into Pfizer's activities in China and Russia,the drugmaker said in a quarterly securities filing (PDF).
美国证券交易委员会(SEC)和司法部(DOJ)的外国腐败部门正在调查辉瑞公司在中国和俄罗斯的活动，这家制药商在一份证券季报中说。
The requests from the two agencies on China came recently in June and August,while the Russian ones arrived last year and have been disclosed in previous reports."We are producing records pursuant to these requests,"Pfizer said in the document.
这两家机构最近分别在6月和8月提出了对中国的要求，而俄罗斯的要求则是去年提出的，并在之前的报告中披露过。"我们正在根据这些要求生产记录，"辉瑞公司在文件中说。
Both probes fall under the Foreign Corrupt Practices Act(FCPA),which forbids U.S.firms and individuals from bribing foreign government officials to benefit their businesses.
这两项调查都属于《反海外腐败法》(FCPA)的管辖范围，该法禁止美国公司和个人向外国政府官员行贿以获取商业利益。
Pfizer knows too well what that law means.In August 2012,the company agreed to pay over$60 million to settle charges by the DOJ and SEC for allegedly violating the FCPA.At the time,the company was accused of paying foreign officials to facilitate drug and formulary approvals,as well as increasing sales in eight countries including China and Russia.
辉瑞非常清楚这项法律意味着什么。2012年8月，该公司同意支付6000多万美元以了结美国司法部和证券交易委员会对其涉嫌违反《反海外腐败法》的指控。当时，该公司被指控贿赂外国官员，以促进药品和药物处方的批准，以及增加在包括中国和俄罗斯在内的8个国家的销售。
In China,for example,Pfizer invited"high-prescribing doctors"in the Chinese government system to fancy meetings that included recreational activities.Various point programs were created,under which government doctors could accumulate points to redeem gifts,according to the SEC's complaint back then.
例如，在中国，辉瑞公司邀请中国政府系统中"开处方量大的医生"参加包括娱乐活动在内的花哨会议。根据当时美国证券交易委员会的投诉，政府设立了各种积分计划，政府医生可以通过积分兑换礼物。
Health Impact News also reported back in July of this year(2020)that former FDA Director Scott Gottlieb now sits on the Board of Directors for Pfizer.
健康影响新闻还报告回到今年7月(2020年)，前 FDA 主任斯科特戈特利布现在是辉瑞公司的董事会成员。
Could Gottlieb's presence at the criminal Pfizer company have anything to do with receiving$1.95 BILLION from Trump's Operation Warp Speed,and their announcement this week that their COVID vaccine is more effective than its competitors?
戈特利布在犯罪公司辉瑞的存在与从特朗普的曲速行动中获得19.5亿美元以及他们本周宣布他们的 ovid 疫苗比竞争对手更有效有关吗？
It is very unlikely that Merck,AZ,J&J and Moderna are just going to sit back and let Pfizer dominate this new,lucrative COVID vaccine market.Look for similar press releases from those companies very soon,touting how effective their vaccines are as well,as they look to get their piece of the pie.
默克公司、AZ 公司、强生公司和摩登纳公司不太可能坐视不管，让辉瑞公司主导这个新的、利润丰厚的COVID疫苗市场。这些公司很快也会发布类似的新闻稿，吹捧他们的疫苗是多么有效，同时他们也希望能分得一杯羹。
Pfizer's stock has already soared,and market analysis is now predicting that due to this announcement their sales will now reach$258 million in the fourth quarter of 2020,with sales in 2021 expected to reach$4.6 BILLION.
辉瑞公司的股票已经飙升，市场分析预计，由于这一声明，2020年第四季度的销售额将达到2.58亿美元，2021年的销售额预计将达到46亿美元。
All of these companies have already received BILLIONS through Operation Warp Speed,so they will ALL come out ahead financially no matter what happens.
所有这些公司都已经通过扭曲速度行动获得了数十亿美元的收入，所以无论发生什么，他们都会在财务上获利。
The real losers will be the citizens of the U.S.and other countries who receive these vaccines.
真正的输家将是美国和其他接种这些疫苗的国家的公民。
Boris Johnson announced today that the U.K.will also purchase 40 million doses of Pfizer's vaccine,to be injected into one third of the U.K.population.
鲍里斯·约翰逊今天宣布，英国还将购买4000万剂辉瑞公司的疫苗，注射给三分之一的英国人。
Listen to Polly Tomney's update:
下面是波莉·汤姆尼的最新消息:
